MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cjca.2012.03.017

Медицинская библиотека · The Canadian journal of cardiology · 2012

Drugs targeting high-density lipoprotein cholesterol for coronary artery disease management.

Katz Pamela M, Leiter Lawrence A

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Many patients remain at high risk for future cardiovascular events despite levels of low-density lipoprotein cholesterol (LDL-C) at, or below, target while taking statin therapy. Much effort is therefore being focused on strategies to reduce this residual risk. High-density lipoprotein cholesterol (HDL-C) is a strong, independent, inverse predictor of coronary heart disease risk and is therefore an attractive therapeutic target. Currently available agents that raise HDL-C have only modest effects and there is limited evidence of additional cardiovascular risk reduction on top of background statin therapy associated with their use. It was hoped that the use of cholesteryl ester transfer protein (CETP) inhibitors would provide additional benefit, but the results of clinical outcome studies to date have been disappointing. The results of ongoing trials with other CETP inhibitors that raise HDL-C to a greater degree and also lower LDL-C, as well as with other emerging therapies are awaited.

Для цитирования: Katz Pamela M, Leiter Lawrence A. Drugs targeting high-density lipoprotein cholesterol for coronary artery disease management.. The Canadian journal of cardiology. 2012. DOI: 10.1016/j.cjca.2012.03.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.